Transcatheter valve implantation for aortic and tricuspid valve regurgitation: A case report
- VernacularTitle:经导管主动脉瓣及三尖瓣置入术治疗主动脉瓣及三尖瓣反流一例
- Author:
Bowen XIAO
1
;
Lulu LIU
1
;
Binggang WU
1
;
Jun SHI
1
;
Yingqiang GUO
1
Author Information
1. Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China
- Publication Type:Journal Article
- Keywords:
Aortic valve regurgitation;
transcatheter aortic valve implantation;
transcatheter tricuspid valve implantation;
tricuspid regurgitation;
case report
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2024;31(06):929-932
- CountryChina
- Language:Chinese
-
Abstract:
Transcatheter aortic valve implantation (TAVI) is an important alternative in treating high-risk patients with aortic valve regurgitation. Transcatheter tricuspid valve implantation (TTVI) is also an important treatment option for high-risk patients with tricuspid regurgitation. We reported a 72-year male patient who underwent TAVI due to severe aortic valve regurgitation using a J-Valve. During a two-year follow-up, the patient developed secondary tricuspid regurgitation to atrial fibrillation, and subsequently received TTVI using a LuX-Valve. Following the interventions, the patient's symptoms were significantly improved, and echocardiography indicated good hemodynamic performance of both transcatheter heart valves. This case highlights the feasibility and effectiveness of performing multiple valve implantations via transcatheter approaches in high-risk elderly patients.
